UNLABELLED: Acetaminophen (APAP) is the leading cause of acute liver injury in the developed world. Timely administration of N-acetylcysteine (N-Ac) prevents the progression of serious liver injury and disease, whereas failure to administer N-Ac within a critical time frame allows disease progression and in the most severe cases may result in liver failure or death. In this situation, liver transplantation may be the only life-saving measure. Thus, the outcome of an APAP overdose depends on the size of the overdose and the time to first administration of N-Ac. We developed a system of differential equations to describe acute liver injury due to APAP overdose. The Model for Acetaminophen-induced Liver Damage (MALD) uses a patient's aspartate aminotransferase (AST), alanine aminotransferase (ALT), and international normalized ratio (INR) measurements on admission to estimate overdose amount, time elapsed since overdose, and outcome. The mathematical model was then tested on 53 patients from the University of Utah. With the addition of serum creatinine, eventual death was predicted with 100% sensitivity, 91% specificity, 67% positive predictive value (PPV), and 100% negative predictive value (NPV) in this retrospective study. Using only initial AST, ALT, and INR measurements, the model accurately predicted subsequent laboratory values for the majority of individual patients. This is the first dynamical rather than statistical approach to determine poor prognosis in patients with life-threatening liver disease due to APAP overdose. CONCLUSION: MALD provides a method to estimate overdose amount, time elapsed since overdose, and outcome from patient laboratory values commonly available on admission in cases of acute liver failure due to APAP overdose and should be validated in multicenter prospective evaluation.
UNLABELLED: Acetaminophen (APAP) is the leading cause of acute liver injury in the developed world. Timely administration of N-acetylcysteine (N-Ac) prevents the progression of serious liver injury and disease, whereas failure to administer N-Ac within a critical time frame allows disease progression and in the most severe cases may result in liver failure or death. In this situation, liver transplantation may be the only life-saving measure. Thus, the outcome of an APAPoverdose depends on the size of the overdose and the time to first administration of N-Ac. We developed a system of differential equations to describe acute liver injury due to APAPoverdose. The Model for Acetaminophen-induced Liver Damage (MALD) uses a patient's aspartate aminotransferase (AST), alanine aminotransferase (ALT), and international normalized ratio (INR) measurements on admission to estimate overdose amount, time elapsed since overdose, and outcome. The mathematical model was then tested on 53 patients from the University of Utah. With the addition of serum creatinine, eventual death was predicted with 100% sensitivity, 91% specificity, 67% positive predictive value (PPV), and 100% negative predictive value (NPV) in this retrospective study. Using only initial AST, ALT, and INR measurements, the model accurately predicted subsequent laboratory values for the majority of individual patients. This is the first dynamical rather than statistical approach to determine poor prognosis in patients with life-threatening liver disease due to APAPoverdose. CONCLUSION: MALD provides a method to estimate overdose amount, time elapsed since overdose, and outcome from patient laboratory values commonly available on admission in cases of acute liver failure due to APAPoverdose and should be validated in multicenter prospective evaluation.
Authors: Yuchao Xie; Mitchell R McGill; Sarah F Cook; Matthew R Sharpe; Robert D Winefield; Diana G Wilkins; Douglas E Rollins; Hartmut Jaeschke Journal: Xenobiotica Date: 2015-04-14 Impact factor: 1.908
Authors: Colleen E Clancy; Gary An; William R Cannon; Yaling Liu; Elebeoba E May; Peter Ortoleva; Aleksander S Popel; James P Sluka; Jing Su; Paolo Vicini; Xiaobo Zhou; David M Eckmann Journal: Ann Biomed Eng Date: 2016-02-17 Impact factor: 3.934
Authors: Alexandre Nuzzo; Shireen Salem; Isabelle Malissin; Abdourahmane Diallo; Nicolas Deye; Antoine Goury; Hervé Gourlain; Nicolas Péron; Eric Vicaut; Sebastian Voicu; Bruno Mégarbane Journal: United European Gastroenterol J Date: 2021-06 Impact factor: 4.623
Authors: Rotem Ben-Shachar; Yifei Chen; Shishi Luo; Catherine Hartman; Michael Reed; H Frederik Nijhout Journal: Theor Biol Med Model Date: 2012-12-19 Impact factor: 2.432
Authors: Paul Manka; Lars P Bechmann; Frank Tacke; Jan-Peter Sowa; Martin Schlattjan; Julia Kälsch; Christoph Jochum; Andreas Paul; Fuat H Saner; Christian Trautwein; Guido Gerken; Ali Canbay Journal: BMC Gastroenterol Date: 2013-04-03 Impact factor: 3.067